Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 2,951–2,975 of 27,380 studies, newest first · page 119 of 1096.

October 2025 25

  1. 2025-10-10

    Hyperactive 20S proteasome enhances proteostasis and ERAD in C. elegans via degradation of intrinsically disordered proteins

    ✓ Peer-reviewed Disease mechanisms Science advances

    Key finding: These findings substantiate a "20S pathway" of proteostasis that directly alleviates protein aggregation and oxidative stress, offering a promising therapeutic angle for neurodegenerative diseases.

  2. 2025-10-10

    Anti-amyloid monoclonal antibody therapies in Alzheimer's disease - a scoping review

    ✓ Peer-reviewed Treatments Neuroscience

    Key finding: Across the sample, reductions in amyloid burden were frequently reported (10 trials), with a smaller subset of studies reporting significant cognitive and functional improvements (4 trials), primarily lecanemab and aducanumab in addition to one pooled analysis of solanezumab.

  3. 2025-10-10

    Previous parity differentially influences cognition in later life depending on dementia status

    ✓ Peer-reviewed Brain tissue and pathology npj Dementia

    Key finding: Among females with dementia, higher parity was associated with reduced episodic memory but enhanced executive function performance, whereas a greater son-to-daughter ratio was associated with reduced executive function performance. +1 more finding

  4. 2025-10-10
  5. 2025-10-10

    Associations of cholinergic white matter hyperintensity volume with cognitive decline and incident dementia in older adults: a cohort study

    ✓ Peer-reviewed Cognitive tests and assessment BMC Geriatrics

    Key finding: During follow-up, cholinergic WMHV was associated with an annual decline of Mini-Mental State Examination (MMSE) (β coefficient, -0.239; P = 0.004), and incident dementia (HR = 3.54; 95%CI: 2.05-6.10). +4 more findings

  6. 2025-10-10

    Supporting informal caregivers of dementia patients in China: action needed

    ✓ Peer-reviewed Caregiving Frontiers in Psychology

    Key finding: Beyond these practical challenges, caregivers often endure significant physical exhaustion and sleep deprivation from the unrelenting demands of caregiving, which can lead to chronic fatigue and deteriorating health (Liu et al., 2022; Mao et al., 2024). +4 more findings

  7. 2025-10-10

    Problem-solving training to improve caregiver burden and depressive symptoms among dementia caregivers: personal and clinical factors of responders vs. non-responders

    ✓ Peer-reviewed Caregiving Frontiers in Public Health

    Key finding: We previously demonstrated that PST/DSJ improved caregiver burden and depressive symptoms among caregivers of adults with Alzheimer’s Disease and related dementias (ADRD), regardless of the number of sessions or boosters received. +4 more findings

  8. 2025-10-09

    Nursing Interventions in Palliative Care for Advanced Dementia: A Systematic Review of Symptom, Relief, Comfort, and Caregiver Support

    ✓ Peer-reviewed End-of-life care Journal of multidisciplinary healthcare

    Key finding: Twenty-three studies from 12 countries were included (8 cluster RCTs, 9 individual RCTs, 6 non-randomized trials). +4 more findings

  9. 2025-10-09

    Brain somatic mutations in Alzheimer's disease: linking genetic mosaicism to neurodegeneration

    ✓ Peer-reviewed Risk genes beyond APOE Molecular neurodegeneration

    Key finding: Recent advancements in single-cell sequencing and genome-wide analyses have revealed higher mutation burdens in neurons, particularly in AD-related genes such as Presenilin 1 (PSEN1), Presenilin 2 (PSEN2) and amyloid precursor protein (APP).

  10. 2025-10-09

    Genome-wide association study provides insights into the genetic basis of Lewy body dementia

    ✓ Peer-reviewed Genetics Molecular psychiatry

    Key finding: We further integrated LBD GWAS with multi-omics datasets, and identified 85 LBD risk genes that were enriched in eight functional clusters including 51 statistically significant pathways (e.g., SYT16 was enriched in the phospholipid binding pathway). +4 more findings

  11. 2025-10-09

    Machine learning-based estimation of the mild cognitive impairment stage using multimodal physical and behavioral measures

    ✓ Peer-reviewed Cognitive tests and assessment Scientific reports

    Key finding: We evaluated the classification performance across various models, including support vector machines, random forest, multilayer perceptron, and convolutional neural network, using unimodal and multimodal datasets. +4 more findings

  12. 2025-10-09

    Risk of stroke associated with risperidone in dementia with and without comorbid cardiovascular disease: population-based matched cohort study

    ✓ Peer-reviewed Vascular contributions The British Journal of Psychiatry

    Key finding: In the overall cohort (28 403 risperidone users and 136 324 mtatched controls), risperidone was associated with increased risk of stroke (adjusted hazard ratio: 1.28; 95% CI: 1.20-1.37). +4 more findings

  13. 2025-10-09

    Primary age-related tauopathy

    ✓ Peer-reviewed Disease mechanisms Acta Neuropathologica

    Key finding: Primary age-related tauopathy (PART) was proposed in 2014 as a neuropathological term to describe patients with Alzheimer's-type medial temporal lobe neurofibrillary degeneration in the absence of significant β-amyloid pathology.

  14. 2025-10-09

    Silodosin as a Novel Inhibitor of Acetylcholinesterase, Butyrylcholinesterase, and BETA-Secretase 1: In Vitro and In Silico Studies

    ✓ Peer-reviewed Risk genes beyond APOE ACS Omega

    Key finding: Previous studies have shown that silodosin has the structural requirements for the inhibition of those three enzymes (AChE, BuChE, and BACE-1), which suggests that it can be useful as a multitarget candidate to treat Alzheimer patients. +4 more findings

  15. 2025-10-09

    Sleep Disorders in Neurodegenerative Diseases with Dementia: A Comprehensive Review

    ✓ Peer-reviewed Risk factors Journal of Clinical Medicine

    Key finding: Dementia is defined as a substantial decline in cognitive function, and it is inherently associated with neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, frontotemporal dementia, and vascular dementia.

  16. 2025-10-09

    Disparities in Access to Deep Brain Stimulation

    ✓ Peer-reviewed Disparities Stereotactic and Functional Neurosurgery

    Key finding: Deep brain stimulation (DBS) is a well-established treatment for several neurological and neuropsychiatric conditions, including movement disorders such as Parkinson's disease, essential tremor, and dystonia, as well as Gilles de la Tourette's syndrome, epilepsy, and obsessive-compulsive disorder.

  17. 2025-10-09

    Hypoglycemia as a risk factor for dementia in diabetes: A systematic review

    ✓ Peer-reviewed Getting a diagnosis Advanced Neurology

    Key finding: Diabetes is a global health concern associated with complications such as cognitive decline and dementia. +3 more findings

  18. 2025-10-09

    Large Language Models: A Paradigm Shift for Dementia Diagnosis and Care

    ✓ Peer-reviewed Getting a diagnosis British Journal of Hospital Medicine

    Key finding: Whilst research into their applications is in its infancy, LLMs can harness vast datasets and powerful algorithms, with significant potential to enhance diagnostic accuracy in dementia, monitor symptom progression, and provide personalised care recommendations.

  19. 2025-10-09
  20. 2025-10-09

    Transkript zur Episode „Lecanemab“

    ✓ Peer-reviewed Treatments EvidenzUpdate

    Key finding: Sind sie die Gamechanger oder vielleicht doch nur Hype? +4 more findings

  21. 2025-10-09

    Leaving no one behind: findings from stakeholder discussions in Maryland on supporting persons living alone with dementia

    ✓ Peer-reviewed Risk factors Planning Practice and Research

    Key finding: Individuals living alone with dementia are rising rapidly, yet this group remains largely unrecognized in dementia care planning. +4 more findings

  22. 2025-10-08

    Probenecid relieves LPS-induced neuroinflammation by modulating the NLRP1 inflammasome pathway in BV2 cells

    ✓ Peer-reviewed Inflammation and the immune system Scientific reports

    Key finding: Probenecid (Prob), a sulfonamide derivative, has demonstrated neuroprotective and anti-inflammatory properties. +2 more findings

  23. 2025-10-08

    Life-Course Burden of Blood Pressure Is Associated With Midlife Cognitive Function

    ✓ Peer-reviewed Risk factors Hypertension (Dallas, Tex. : 1979)

    Key finding: Trajectories of systolic BP were separated markedly around 25 to 45 years of age, with the group below the median of cognition score having higher levels of systolic BP than the group above the median. +4 more findings

  24. 2025-10-08

    HSV-1 as a Potential Driver of Alzheimer’s Disease

    ✓ Peer-reviewed Disease mechanisms Pathogens

    Key finding: As life expectancy continues to increase worldwide, HSV-1 should remain a focus to minimize its associated health complications within the aging population. +4 more findings

  25. 2025-10-07

    Cross-Ancestry Polygenic Risk Scores Enhance Alzheimer's Disease Risk Prediction in Multiethnic Cohorts

    ⚠ Preprint — not yet peer-reviewed Genetics medRxiv : the preprint server for health sciences

    Key finding: The cross-ancestry Bayesian PRS model demonstrated the highest predictive performance in non-European populations. +2 more findings

    Scored 25 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

Browse the library by subject, with the full score breakdown →